EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC-ND 4.0

European reclassification of non-invasive brain stimulation as class III medical devices: A call to action

Chris Baeken, Martijn Arns, Jerome Brunelin, Lorena Chanes, Igor Filipcic, Ana Ganho-Ávila, Marco Hirnstein, Fady Rachid, Alexander T Sack, Jacinta O'shea, Giordano D'urso, Andrea Antal

Brain Stimulation · 2023-03 · 16 (2) · 564-566

DOI: 10.1016/j.brs.2023.02.012 ↗

Kurz gefasst

Editorial in der Zeitschrift Brain Stimulation, 2023-03. Verfasst von Chris Baeken und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry (GHEP) lab, Ghent University, Ghent, Belgium; Dep…. Hauptthemen laut MEDLINE: Brain. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Within the European Union (EU), and by contrast with other countries (notably the USA), only a limited number of insurance companies reimburse treatment with repetitive transcranial magnetic stimulation (rTMS) and none with transcranial electrical stimulation (tES). As a consequence, there is significant risk that treatment availability and investment in research and clinical developments in non-invasive brain stimulation (NIBS) in Europe will fall behind. Unexpectedly, a sudden unwelcome regulatory change has made the European situation even worse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainUnited StatesUnited States Food and Drug AdministrationEquipment Safety

Autor:innen und Institutionen

  • Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent Experimental Psychiatry (GHEP) lab, Ghent University, Ghent, Belgium; Department of Psychiatry, University Hospital (UZBrussel), Brussels, Belg…
  • Research Institute Brainclinics, Nijmegen, the Netherlands.
  • CH Le Vinatier, Université Claude Bernard Lyon 1, CNRS, INSERM, Centre de Recherche en Neurosciences de Lyon CRNL U1028 UMR5292, PSYR2, F-69500, Bron, France.
  • Department of Clinical and Health Psychology-Institut de Neurociències, Universitat Autònoma de Barcelona, Catalunya, Spain; Serra Húnter Programme, Generalitat de Catalunya, Spain.
  • Psychiatric Hospital "Sveti Ivan", Zagreb, Croatia.
  • Faculty of Psychology and Educational Sciences, University of Coimbra, 3000-115, Coimbra, Portugal.

Förderung

  • Wellcome Trust

Zitieren

APA

Baeken, C., Arns, M., Brunelin, J., Chanes, L., Filipcic, I., Ganho-Ávila, A., Hirnstein, M., Rachid, F., Sack, A. T., O'shea, J., D'urso, G., & Antal, A. (2023). European reclassification of non-invasive brain stimulation as class III medical devices: A call to action. Brain Stimulation, 16(2), 564-566. https://doi.org/10.1016/j.brs.2023.02.012

Vancouver

Baeken C, Arns M, Brunelin J, Chanes L, Filipcic I, Ganho-Ávila A, et al. European reclassification of non-invasive brain stimulation as class III medical devices: A call to action. Brain Stimulation. 2023;16(2):564-566. doi:10.1016/j.brs.2023.02.012

BibTeX
@article{Baeken2023,
  author = {Baeken, Chris and Arns, Martijn and Brunelin, Jerome and Chanes, Lorena and Filipcic, Igor and Ganho-Ávila, Ana and Hirnstein, Marco and Rachid, Fady and Sack, Alexander T and O'shea, Jacinta and D'urso, Giordano and Antal, Andrea},
  title = {European reclassification of non-invasive brain stimulation as class III medical devices: A call to action},
  journal = {Brain Stimulation},
  year = {2023},
  volume = {16},
  number = {2},
  pages = {564--566},
  doi = {10.1016/j.brs.2023.02.012}
}
Kostenlos starten →